Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

October 24, 2023

IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

News Daily News

IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

July 27, 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

June 09, 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

May 31, 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

News Conference News EuroPCR 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

May 17, 2023

March 2023 News Roundup

News Opinion CV Team Dispatch

March 2023 News Roundup

March 15, 2023

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

January 24, 2023

Brachytherapy Remains an Option for DES In-Stent Restenosis

News Daily News

Brachytherapy Remains an Option for DES In-Stent Restenosis

Yael L. Maxwell

January 12, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.